Inhaled prostacyclin analogues in COVID-19 associated acute respiratory distress syndrome: scientific rationale.
Eka Prasetya Budi MuliaKevin LukePublished in: The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology (2021)
Inhaled prostacyclin could be considered in patients with refractory, life-threatening hypoxia despite standard management.